FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect.
Yao Z, Xiao Y, Li W, Kong S, Tu H, Guo S, Liu Z, Ma L, Qiao R, Wang S, Chang M, Zhao X, Zhang Y, Xu L, Sun D, Fu X.
Yao Z, et al. Among authors: kong s.
J Assoc Res Otolaryngol. 2024 Apr 15. doi: 10.1007/s10162-024-00945-2. Online ahead of print.
J Assoc Res Otolaryngol. 2024.
PMID: 38622383